GGrantIndex
Sort

64,565 grants matching drug discovery

Institute for Clinical and Translational Research

$1,294,527
Daniel Ernest Ford · Johns Hopkins University · KL2 · FY2013 · TR

CENTER OF EXCELLENCE FOR PROSTATE CANCER RESEARCH, EDUCATION AND COMMUNITY SERVIC

$1,294,436
Shafiq A Khan · Clark Atlanta University · P20 · FY2007 · MD

ANTICANCER DRUGS ACTIVE AGAINST CELL CYCLE AND SIGNAL PA

$1,294,032
University Of Arizona · U19 · FY2002 · CA

ANTICANCER DRUGS ACTIVE AGAINST CELL CYCLE AND SIGNAL PA

$1,293,918
University Of Arizona · U19 · FY2003 · CA

Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder

$1,293,692
Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2019 · AA

Developmental Research Projects Program (DRPP)

$1,293,675
Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · P20 · FY2023 · GM

Establishing Sleep Apnea as a non-cognitive phenotype of brainstem ADRD pathologies in older adults

$1,293,402
Veronique Vanderhorst · Beth Israel Deaconess Medical Center · R01 · FY2021 · AG

Natural Inhibitors of Carcinogenesis

$1,292,922
John M Pezzuto · Purdue University · P01 · FY2006 · CA

Drug Repurposing Screening for Rare and Neglected Diseases

$1,292,761
Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

SBIR Phase II:A low-cost instrument for rapid sub-micron particle size and concentration measurement

$1,292,655
Jean-Luc Fraikin · Spectradyne Llc · · FY2015 · TIP

Bioanalysis, Drug Metabolism and New Drug Discovery

$1,292,299
Josephine Earley · National Institute On Aging · ZIA · FY2018 · AG

NEW DRUG TARGETS FOR APOPTOSIS

$1,291,932
University Of Arizona · P01 · FY2001 · CA

TREAT AD Admin

$1,291,930
Allan I Levey · Emory University · U54 · FY2025 · AG

Natural Inhibitors of Carcinogenesis

$1,291,843
John M Pezzuto · Purdue University · P01 · FY2007 · CA

timsTOF fleX with MALDI-2 for Advanced Mass Spectrometry Imaging

$1,291,625
Kristine Glunde · Johns Hopkins University · S10 · FY2021 · OD

Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases

$1,291,515
Kevin Kit Parker · Massachusetts General Hospital · U01 · FY2012 · HL

DartCF: The Dartmouth Cystic Fibrosis Research Center

$1,291,515
Dean R Madden · Dartmouth College · P30 · FY2025 · DK

Inhaled Fasudil and DETA NONOate CAR-Targeted Liposomes for PAH

$1,291,298
Fakhrul Ahsan · Vascular Biosciences · R42 · FY2021 · HL

Pathobiology of Neurodegeneration in C9ORF72 Repeat Expansion

$1,291,133
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2014 · NS

Pathobiology of Neurodegeneration in C9ORF72 Repeat Expansion

$1,291,133
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2015 · NS

AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning

$1,291,066
Zhongming Zhao · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · AG

2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership

$1,290,685
Ernest Martinez · University Of California Riverside · U54 · FY2024 · CA

Transcriptome Characterization of Medicinal Plants Relevant to Human Health

$1,290,553
Norman George Lewis · Washington State University · RC2 · FY2010 · GM

Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium

$1,290,419
Bruce M Psaty · University Of Washington · R01 · FY2013 · HL

Developmemt of Novel Treatments for Nicotine Addiction

$1,290,333
Linda P Dwoskin · University Of Kentucky · U19 · FY2007 · DA